Page 360 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 360

Page 9 of 10  Original Research


              formulations,  the  association  remained  when  corrected  for   included all children aged 5 years or older when addressing
              age. Possibly an easier routine with syrups does not require   their HRQoL. Although we suggest doing similar research in
              the  need  to  disclose.  Children  on  PI-based  regimens  with   other settings to ensure generalisability of the data, another
              stavudine and didanosine had less likely received disclosure.   strength of this study was the reasonable sample size.
              Current  guidelines recommend  replacing  stavudine  and
              didanosine with abacavir  and will therefore not be part of   Conclusion
                                  29
              future  regimens. Multiple  clinical characteristics associated
              with disclosure in univariate analyses attenuated in   This cross-sectional study shows a low proportion of children
              multivariate analyses, explained by the child’s age (lopinavir/  knowing about their HIV status. Older age of the child was
              ritonavir syrup, NNRTI-based regimens, efavirenz regimens,   strongly associated with disclosure. We found a less stringent
              duration on treatment and starting treatment in the first year   need for caregivers to disclose the child’s HIV status to the
              of life). Children on lopinavir/ritonavir syrup were less likely   child when ART was tolerated well and no condition-related
              disclosed. This could be explained by the regimen generally   difficulties were experienced (e.g. high HRQoL for both the
              being given to young children and being changed to tablet   child and the caregiver and family activities not affected by
              form for older children. Although the general experience of   chronic disease). Well-functioning families, with caregivers
              side effects did not affect disclosure, side effects affecting the   who received higher level of education and children from
              central nervous system, unusual dreams and trouble sleeping   households with better SES, provided an environment
                                              29
              (efavirenz) and severe rash (nevirapine)  likely contributed   enabling and promoting disclosure of the HIV status to the
              to  the  decision  of  caretakers  to  disclose  the  HIV  status  to   child. Disclosure can only be beneficial when there is a
              children on regimens including NNRTIs. Children who were   supportive social structure. Non-disclosure can indicate a
              on treatment for longer duration had more likely received   sub-optimal social structure, which could negatively affect
              disclosure. Guidelines in South Africa regard all HIV-positive   adherence and viral suppression. In order to successfully
              children eligible to initiate ART irrespective of CD4 count or   address disclosure, the complex social context needs to be
              clinical staging.  Older children, who are more likely on   taken into account. When families are in a good space, there
                          29
              treatment for longer duration, more often receive disclosure,    is no pressing need to start the disclosure process. However,
                                                             10
              potentially  explaining why  the  association  attenuated  in   these circumstances positively enable the disclosure process.
              multivariate  analysis.  Other  studies  have  confirmed  the   Targeting these families for disclosure interventions and the
              association we find between longer time on  ART and   support of families to reach such an enabling environment
              disclosure.  Children who started treatment in the first year   can therefore be especially successful.
                      25
              of life, however, less likely received disclosure. Disclosure did
              not seem as urgent for caregivers when the same routine with   Acknowledgements
              their child could be maintained from birth and no failure of
              treatment occurred.                                   The authors thank the study participants, the staff at the
                                                                    clinical site, TC Newman Hospital and  Anova Health
              Socio-economic characteristics associated with disclosure   Institute and also Mrs H. Lesch for her assistance with the
              included family functioning, affected daily activities and   data collection.
              waterborne sanitation.  Although some studies have
              described an association with disclosure and the child’s   Competing interests
              family situation, 10,14  no specific measures for family
              functioning or activities were reported in the literature.   The authors have no conflict of interests.
                                                     24
              Indicators of SES including financial problems  and the
                              14
              child being hungry  are reported in the literature as a   Authors’ contributions
              predictor of disclosure.  Although we did not find an   S.L.v.E. and  A.M.v.F. conceived this  cohort  study. S.L.v.E.,
              association between SES index and disclosure, despite a   A.M.v.F., M.F.C. and R.P.H.P. contributed to the conception of
              large number of people living in informal settlements, we   design and methodology of the study and prepared the
              found that children from households with access to    protocol. S.L.v.E. and P.K. contributed to acquisition of data,
              waterborne sanitation had more likely received disclosure.   facilitated by C.G. S.L.v.E. prepared the data sets and
              Informal living conditions more often lack waterborne   conducted the statistical analyses, which were checked by
              sanitation,  are  more  densely  populated  and  lack  privacy   A.M.v.F., R.P.H.P. and M.O.K.  All authors contributed
              required to support the disclosure process.
                                                                    substantially to the interpretation of the data. S.L.v.E. drafted
                                                                    the manuscript and all authors revised the manuscript
              A limitation of our study was the reliance on medical records   critically for important intellectual content.  All authors
              for viral load and CD4 count results. In addition, the   reviewed and approved the final manuscript.
              questionnaire did not include topics like experience with or
              perspectives on disclosure. Literature focuses on healthcare
              providers’ perspective 30,31,32  or caregivers’ perspective. 12,14,22,33    Funding Information
              The child’s perspective on disclosure is rarely or not studied   This  research  received  no  specific  grant from any  funding
              at all.  A strength of our  study was that our interviews   agency in the public, commercial or not-for-profit sectors.

                                           http://www.sajhivmed.org.za 353  Open Access
   355   356   357   358   359   360   361   362   363   364   365